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Objective: To investigate the effect of long term high intensity weightbearing exercises on radiological
damage of the joints of the hands and feet in patients with rheumatoid arthritis (RA).
Methods: Data of the 281 completers of a 2 year randomised controlled trial comparing the effects of
usual care physical therapy (UC) with high intensity weightbearing exercises were analysed for the rate of
radiological joint damage (Larsen score) of the hands and feet. Potential determinants of outcome were
defined: disease activity, use of drugs, change in physical capacity and in bone mineral density, and
attendance rate at exercise sessions.
Results: After 2 years, the 136 participants in high intensity weightbearing exercises developed
significantly less radiological damage than the 145 participants in UC. The mean (SD) increase in damage
was 3.5 (7.9) in the exercise group and 5.7 (10.2) in the UC group, p = 0.045. Separate analysis of the
damage to the hands and feet suggests that this difference in rate of increase of damage is more
pronounced in the joints of the feet than in the hands. The rate of damage was independently associated
with less disease activity, less frequent use of glucocorticoids, and with an improvement in aerobic fitness.
Conclusion: The progression of radiological joint damage of the hands and feet in patients with RA is not
increased by long term high intensity weightbearing exercises. These exercises may have a protective
effect on the joints of the feet.
R
heumatoid arthritis (RA) is a disease characterised by
local bone destruction and accompanied by systemic
bone loss. Locally, synovial inflammation results in
periarticular osteoporosis and subsequent development of
bone erosions, with the joints of the hands and feet most
commonly affected. At a systemic level, bone loss manifests
itself in osteoporosis. This bone loss is assumed to be the
result of several factors such as disease activity, use of
glucocorticoids, and a decrease in physical capacity.1–5 In
recent cross sectional studies, an association between local
and systemic bone loss was found,6 7 and more bone erosions
were associated with a lower bone mineral density (BMD). It
has been suggested that local and systemic bone loss are
interrelated, with the osteoclast being the common effector
cell. In active synovitis, increased production of proinflam-
matory cytokines is presumed to be responsible for the
activation of osteoclasts locally and systemically, and
consequent bone loss.8–10
Recently, a long term high intensity weightbearing exercise
programme was shown to be effective in increasing the
physical capacity, functional ability, and emotional status of
patients with RA when compared with usual care physical
therapy (UC).11 In that randomised controlled trial, the
effects of the exercises on bone loss were also examined. No
additional damage to the large weightbearing joints was
found, with the exception of a small group of patients who
had significant baseline damage in these joints. This limited
additional damage was attributed to excessive wearing.
Exercise was found to prevent systemic bone loss.12 The
decline in BMD of the hip was postponed in the exercise
group in comparison with the UC group. This effect was
attributed to the long term high intensity weightbearing
exercises, effective in increasing aerobic fitness and muscle
strength.
At this moment, little is known about the effects of
exercise on radiological joint damage of the hands and feet.
Four studies have reported the effects of long term intensive
exercises on the radiological damage of the joints of hands
and/or feet.13–16 In one study a decreased rate of radiological
damage of the joints of the hands and/or feet was found in
the exercise group in comparison with control.13 The
remaining three studies14–16 did not show any significant
difference in the rate of damage of the joints of hands and
feet between the exercise and the control group. Possible
reasons for this lack of consistency are the low numbers of
participants in each study and differences in design,
including differences in the impact loading of the skeleton.
To investigate the effect of long term high intensity
weightbearing exercises on the radiological joint damage of
the hands and feet we used the data of a large randomised
controlled trial (the Rheumatoid Arthritis Patients In
Training (RAPIT) study).11 12 Secondly, we examined which
exercise related factors predict, after adjusting for disease
activity and use of glucocorticoids, the local bone destruction
of the joints of hands and feet in these patients.
PATIENTS AND METHODS
Study participants
The patients under investigation are completers of the RAPIT
study. The RAPIT study was originally designed to investigate
the effectiveness and safety of long term high intensity
weightbearing exercises. This study provided data from
2 years, from 1998 until 2000. The patients who were
recruited for the RAPIT study had to fulfil the following
Abbreviations: ACR, American College of Rheumatology; AF, aerobic
fitness; AUC, area under the curve; BMD, bone mineral density; DAS4,
Disease Activity Score with four variables; DMARD, disease modifying
antirheumatic drug; DXA, dual photon x ray absorptiometry; HAQ,
Health Assessment Questionnaire; ICC, intraclass correlation coefficient;
IQR, interquartile range; MS, muscle strength; RA, rheumatoid arthritis;
RAI, Ritchie Articular Index; RAPIT, Rheumatoid Arthritis Patients In
Training; SDD, smallest detectable difference; UC, usual care
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inclusion criteria: age 20–70 years, RA according to American
College of Rheumatology (ACR) criteria 1987,17 ACR func-
tional class I–III,18 stable disease modifying antirheumatic
drug (DMARD) intake in past 3 months, and no prosthesis of
a weightbearing joint. Those patients who met these criteria
and who gave written informed consent were subsequently
randomised.
The medical ethics committee of each participating centre
approved the study protocol.
RAPIT study protocol
For the RAPIT study, 309 patients were randomised (fig 1).
Nine randomised patients refused participation immediately
after randomisation and did not cooperate in baseline
measurements. Over the period of 2 years, 19 patients did
not complete this trial for different reasons.11 From the 281
participants who completed the RAPIT study (completers),
136 were participants in the high intensity weightbearing
exercise programme (exercise group) and 145 were partici-
pants in the control group (UC group).
The attending physicians of all participants were informed
about the treatment allocation and had free choice about
their medical prescriptions and other treatment strategies.
Patients assigned to the UC group were treated by a
physical therapist if regarded necessary by their attending
physician. It was agreed that they would not participate in
any supervised or unsupervised high intensity exercise
sessions during the trial period. The patients randomly
allocated to the exercise group participated in a supervised
intensive biweekly group exercise programme. None of the
patients in either group were explicitly encouraged to
participate in any free time physical activity.
Attendance at any group or individual physical therapy
sessions apart from the RAPIT programme was recorded in
both groups.
Baseline and follow up measurements
At baseline, sociodemographic characteristics were registered
as well as disease duration, presence of rheumatoid factor
(RF), past and present use of DMARDs, and current use of
oral glucocorticoids.
Outcome variables
The primary outcome variable in the present study on local
bone destruction was defined as the change in radiological
joint damage of the hands and feet after 2 years of study. The
following potential determinants of change in radiological
joint damage were included: disease activity, the use of drugs
(DMARDs and glucocorticoids), change in physical capacity
(aerobic fitness and muscle strength), change in BMD of the
hip, and attendance rate at exercise sessions.
Radiological joint damage of the hands and feet
Radiological joint damage of the hands and feet was assessed
using the method devised by Larsen et al19 and modified by
Scott et al.20 The following joints were assessed: the 10
proximal interphalangeal joints, the 10 metacarpophalangeal
joints, the wrists (scored as one unit and multiplied by five),
the fifth to the second metatarsophalangeal joints, and the
first interphalangeal joints. According to this method the
Larsen score of the hands and feet (Larsen score) varies from
0 (no joint space narrowing, no erosions) to 200 (maximum
possible damage). The number of damaged joints was also
assessed. The number of joints with a score .0 was counted
and varies from 0 (no joint with score .0) to 32 (each joint
assessed damaged).
A single observer (AC) scored the radiographs. All radio-
graphs were scored without information on their time
sequence, the patient’s identity, and the treatment received.
The intraclass correlation coefficient (ICC) based on repeated
readings of 19 radiographs by the single observer with
4 weeks’ interval between the readings was 0.96, mean
difference (SD) in Larsen score 0.69 (6.7).
Disease activity
Disease activity was assessed with the original Disease
Activity Score with four variables (DAS4).21 The DAS4 is a
compiled index based on a 44 joint count for swelling (SW44;
Figure 1 Recruitment procedure.
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range 0–44), tender joint count (Ritchie Articular Index
(RAI); range 0–78), erythrocyte sedimentation rate, and the
patient’s global assessment of disease activity measured on a
visual analogue scale (range 0–100). The DAS4 ranges from 0
(no disease activity) to 10 (severe disease activity). The
changes during the 2 year study period preceding the follow
up measurement of the end points were expressed as area
under the curve (AUC DAS4).
Drug use
Drug use (oral glucocorticoids and DMARDs) was reported by
the patients at each 3 monthly visit. The use of glucocorti-
coids is presented after conversion into the number of
months from the start of the study during which the patients
reported the use. The number of months of use can thus vary
from 0 (never used) to 24 (used every month of the study).
The cumulative dose of prednisolone was also calculated.
Any changes in the use of DMARDs were interpreted
by a rheumatologist (ZdJ) as changes in RA activity:
0=decreased disease activity; 1=no change in disease
activity; 2= increased disease activity. Changes in the use
of DMARDs after 2 years can thus vary from 0 (decrease in
disease activity at every visit) to 16 (increase in disease
activity at every visit).
Physical capacity
Physical capacity was determined by aerobic fitness (AF) and
muscle strength (MS). AF was measured by a standardised
ergometer test and is given in watts (W).22 MS of the knee
extensors was measured with an isokinetic dynamometer at
an angle velocity of 60 /˚s and is given in newtons (N)23
Bone mineral density
BMD measurements of the hip in the total hip region were
carried out by dual photon x ray absorptiometry (DXA) and
are given in g/cm2. Hologic QDR-2000 was used in one centre
(Amsterdam), QDR-4500 in two other centres (Leiden, The
Hague). The scanning and standard quality procedures were
followed. All measurements of one patient were performed
using the same DXA. The in vitro reproducibility expressed as
coefficient of variation was 3.7% and 2.6% for the Hologic
QDR-2000 and Hologic QDR-4500, respectively.
Attendance rate
Attendance rate was recorded for each individual participant
in the exercise group and is expressed as a percentage of the
maximum possibly attended exercise sessions. For the
attendance rate of participants in the UC group, 0 was
substituted.
Assessments
The assessments were done at baseline and at 6, 12, 18, and
24 months. Moreover, every 3 months the participants
reported on their drug use, and disease activity and physical
capacity were assessed. Bone mineral density and radiological
joint damage were assessed only at baseline and after 12 and
24 months.
All clinical outcome assessments were done by four
research physical therapists who were trained thoroughly
before the trial and after 1 year. A manual of procedures and
assessment techniques was available in each centre. A
reproducibility study in 19 patients showed ICCs for AF,
MS, SW44, and RAI of 0.97, 0.98, 0.83, and 0.92, respectively.
Statistical analysis
Because the RAPIT study was primarily designed with the
Health Assessment Questionnaire (HAQ) as a primary
outcome variable, the target sample size was calculated to
detect a difference of 0.20 in the change of the HAQ.11 This
difference is assumed to be clinically relevant.24 Based on 0.9
power to detect a significant difference (p=0.05, two sided)
and assuming a standard deviation of 0.5, 119 patients would
be required for each study group. To compensate for an
expected dropout rate of about 20% we planned to enrol at
least 150 patients in each study group. Final analyses are
based on an intention to treat as initially assigned on the data
of the 281 completers of the study.
We used the smallest detectable difference (SDD) of the
change score calculated according to Lassere et al25 as a
threshold for relevant progression in radiological damage of
the joints of hands and feet and as a surrogate for clinically
relevant increase in damage
At all times, measures with a Gaussian distribution are
expressed as a mean (SD) and measures with a non-Gaussian
distribution as median and interquartile range (IQR). At
baseline, differences between the groups were analysed with
the Mann-Whitney U test or x2 test, where appropriate.
To analyse the effects of the long term high intensity
weightbearing exercise programme on the radiological joint
damage of the hands and feet after 1 and 2 years the changes
from baseline (follow up minus baseline measurement) were
compared by analysis of variance. They are presented as a
mean difference in change between the groups (95%
confidence interval (95% CI)) after correction for the baseline
differences. To compare the effects over the total period of
2 years, repeated measures were analysed with mixed effects
analysis of variance models, with patient number as random
factor, and treatment, time, and the treatment by time
interaction as fixed effects. Values of p(0.05 are considered
statistically significant.
Multivariate analyses were used to explore the relation-
ships between the dependent variable change in radiological
joint damage and the independent variables—disease activ-
ity, use of DMARDs and glucocorticoids, change in physical
capacity and in BMD, and attendance rate at the exercise
sessions. These analyses were performed as a multiple linear
regression model. Based on the supposed clinical relevance
and the results of the multivariate analysis, variables were
successively removed from the multiple regression models in
a backward fashion. The risk for development of radiological
damage is expressed as unstandardised regression coefficient
(B), SE, and a level of significance (p value). All analyses
were performed using SPSS program, version 10.0.
RESULTS
Table 1 shows the baseline characteristics of all 281
completers of the RAPIT study.
At baseline, the participants of the UC group and the
exercise group had similar characteristics, except for a
slightly longer duration of RA and more radiological joint
damage of the hands and feet in the UC group (Larsen score
hands and feet). When the radiological damage of the hands
and feet was analysed separately, the treatment groups
appeared to differ significantly only in damage of the hands
(p=0.043) but not of the feet (p=0.085) (table 2). The
mean changes in variables are, therefore, where appropriate,
presented after correction for baseline differences.
Participation in exercises
In the course of the 2 years, 80 (55%) and 46 (34%) of the
participants in the UC and the exercise group, respectively,
were treated individually by a physical therapist at least once.
The physical therapy involved hydrotherapy and different
types of physical therapy (passive, active, or applications).
None of the patients participated in any high intensity
weightbearing exercises except in the programme under
study.
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Use of DMARDs and glucocorticoids
At baseline, 26 (19%) of the exercise and 15 (10%) of the UC
group completers were using no DMARD (p=0.061); 97
(71%) of the exercise group v 115 (79%) of the UC group
completers were using monotherapy (p=1.000); and 13
(9.6%) v 15 (10.3%) combination therapy (p=0.845). After
2 years, 31 (23%) of the exercise v 34 (23%) UC group
participants were using no DMARD (p=0.886); 82 (60%) v
97 (67%) were using monotherapy; and 23 (17%) v 14 (10%)
combination therapy. None of the patients were treated with
a tumour necrosis factor a blocking agent. The differences
between the groups in the use of DMARDs did not reach
significance. In addition, no differences between the groups
were found in disease activity as judged by DAS411 or changes
in use of DMARDs during the study period,
The mean (minimum–maximum) cumulative dose of
glucocorticoids was 63.8 (0.0–1069.0) mg in the exercise
and 57.1 (0.0–900.0) mg prednisolone equivalents in the UC
group (p=0.284). After 2 years, 21 (15%) completers of the
exercise group and 16 (11%) completers of the UC group had
ever used glucocorticoids (p=0.224).
Effect of a long term high intensity exercise
programme on rate of damage of the small joints
Owing to missing radiographs of either the hands or the feet,
or both, the Larsen score could be determined at baseline in
Table 1 Baseline demographic and disease related characteristics of 281 RAPIT study
completers
All completers Exercise group UC group
(n = 281) (n = 136) (n = 145)
Demographic characteristics
Age (years) 54 (16) 54 (16) 54 (16)
Body mass index (kg/m2) 26 (6) 26 (5) 26 (6)
Female, No (%) 225 (80) 110 (81) 115 (79)
Postmenopausal women, No (% of the women) 138 (61) 63 (57) 75 (65)
Disease related characteristics
Duration of RA (years) 6 (9) 5 (7) 7 (11)*
Rheumatoid factor positive, No (%) 197 (70) 96 (71) 101 (70)
DMARDs used in the past (n) 2 (1–2) 1 (1–2) 2 (122)
Current use of DMARDs, No (%) 241 (86) 111 (82) 130 (90)
Current use of glucocorticoids, No (%) 25 (8.9) 11 (8.1) 14 (9.7)
ESR (mm/1st h) 16 (21) 16 (21) 16 (22)
44 Joint count for swelling (0–44) 12 (12) 12 (12) 11 (12)
Ritchie Articular Index (0–78) 8.0 (10.0) 8 (10.0) 9 (11.0)
Patient’s global assessment of disease activity
(0–100)
3.2 (4.1) 3.0 (4.0) 3.3 (4.3)
DAS4 (0–10) 3.3 (0.7) 3.2 (1.4) 3.4 (2.0)
HAQ (0–3) 0.63 (0.75) 0.63 (0.88) 0.63 (0.84)
Aerobic fitness (W) 162 (74) 162 (74) 162 (74)
Larsen score (0–200) 31.0 (58.0) 24.0 (54.5) 37.5 (54.5)*
Bone mineral density (g/cm2) 0.909 (0.194) 0.912 (0.210) 0.906 (0.187)
Except when indicated otherwise, values are median (IQR).
IQR, interquartile range expressed as a net result of the 75th centile–25th centile; RAPIT, Rheumatoid Arthritis
Patients In Training; UC, usual care; DMARDs, disease modifying antirheumatic drugs; DAS4, disease activity
score with four variables; HAQ, Health Assessment Questionnaire.
*p,0.05 by Mann-Whitney U test or x2 test, where appropriate.
Table 2 Radiological joint damage of the hands and feet (measured by the Larsen score)
of the 281 completers of the RAPIT study
Radiological damage Exercise group UC group
Mean difference (95% CI)*
Exercise2UC
Hands and feet
Baseline (n = 275) 34.5, 24.0 (54.5) 43.7, 37.5 (54.5)
Change after 1 year (n = 268) 2.0, 0.0 (4.0) 3.1, 0.0 (6.0 20.9 (22.6 to 0.0.7)
Change after 2 years (n = 272) 3.6, 1.0 (6.0) 5.7, 2.0 (9.0) 22. 1 (24.2 to 0.2)
p = 0.045
Hands only
Baseline (n = 277) 23.8, 17.0 (39.0) 30.6, 25.0 (48.0)
Change after 1 year (n = 272) 1.5, 0.0 (2.3) 2.1, 0.0 (3.0) 20.5 (21.8 to 0.9)
Change after 2 years (n = 274) 2.9, 0.0 (5.0) 4.2, 1.0 (7.0) 21.2 (23.1 to 0.7)
p = 0.132
Feet only
Baseline (n = 276) 10.8, 6.0 (19.0) 13.1, 9.0 (20.0)
Change after 1 year (n = 271) 0.5, 0.0 (1.0) 0.9, 0.0 (2.0) 20.5 (21.1 to 0.2)
Change after 2 years (n = 273) 0.7, 0.0 (1.0) 1.5, 0.0 (3.0) 20.8 (21.6 to 20.1)
p = 0.047
Baseline values are given as the mean, median (IRQ). IRQ, interquartile range is expressed as a net result of the
75th–25th centile.
Change values are given as mean, median (IQR) difference from baseline values.
*Mean difference (95% confidence interval (95% CI)) between change in the exercise group and change in the UC
group after correction for baseline differences; p value is a result of mixed effects analysis of variance.
RAPIT, Rheumatoid Arthritis Patients In Training; UC, usual care.
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only 275 (142 of the UC and 133 of the exercise group)
completers. Also, after 1 year the change in Larsen score
could be calculated in only 268 (138 of the UC and 130 of the
exercise group) and after 2 years in 272 (139 of the UC and
133 of the exercise group) completers.
Table 2 demonstrates that the damage of the hands and
feet (Larsen score of the hands and feet) increased
significantly less in the participants in the exercise group
than in the UC group participants. Separate analysis of the
damage of the hands and feet suggests that this difference in
rate of increase in damage was more pronounced in the joints
of the feet than in those of the hands.
The SDD of the progression of the Larsen score, based on the
scores of the repeated measurements of the single observer,
amounts to 11.5. Using the SDD as a threshold for relevant
progression in damage of the small joints, we found that it was
exceeded in 30/139 (22%) UC group participants and 15/133
(11%) exercise group participants (p=0.022).
At baseline, the median (IQR) number of joints of hands
and feet damaged (defined as Larsen score .0) was 8.0
(12.4) in the UC and 6.2 (13.7) in the exercise group
(p=0.176). When analysed separately for the joints of hands
and feet, again, no significant differences between the two
groups were noted.
After 2 years the number of damaged joints increased in
both groups and this was true for both hands and feet and
also when analysed separately. Mean (SD) increase in the
total number of damaged joints was 1.3 (2.1) and 0.8 (1.1) in
the UC and RAPIT groups (p=0.142), respectively, and this
increase in the number of newly damaged joints was similar
in the hands and feet (data not shown).
Relationship between the disease, disease treatment
and exercise related factors, and the change in
radiological joint damage after 2 years
To illustrate the relationship between disease, disease
treatment and exercise related factors and the change in
radiological joint damage (expressed as Larsen score) after
2 years, we constructed two subgroups based on the
distribution of change in radiological joint damage. Based
on a mean change in Larsen score after 2 years (4.67) we
constructed a subgroup with change in Larsen score (4.67
(termed slow increase in damage) and a subgroup with
change .4.67 (termed fast increase in damage).
Table 3 shows that, in comparison with patients with a
slow increase in damage, the patients with a fast increase in
damage were those with a significantly higher baseline
Larsen score, higher disease activity during the study (as
defined by AUC DAS4 and by changes in use DMARDs), and
those patients who showed a decrease instead of increase in
aerobic fitness. Furthermore, the patients with fast increase
in damage showed a trend towards more frequent use of
glucocorticoids, less improvement in muscle strength, faster
loss of BMD, and a lower attendance rate at exercise sessions
than patients with a slow increase in damage.
To establish which of these factors was associated with the
outcome we performed univariate analyses. The following
factors were explored: disease activity (defined by AUC
Table 3 Relationship between the disease, disease treatment and exercise related
factors* and the change in radiological joint damage after 2 years
Patients in each
group (n)
Slow increase in
damage
Fast increase in
damage
Baseline Larsen score (0–200), median (IQR) 166/106 20.0 (48.3) 51.0 (53.5)
AUC DAS4 166/106 20.3 (7.8) 23.9 (8.0)
Use of DMARDs (0–16) 166/106 0.3 (0.4) 0.4 (0.4)
Use of glucocorticoids (0–24), months 166/106 1.9 (6.0) 3.2 (7.2)
Change in muscle strength (N), median (IQR) 156/99 8.25 (31.9) 3.5 (31)
Change in aerobic fitness (W), median (IQR) 151/97 0.15 (46.10) 20.1 (39.5)
Change in BMD (g/cm2) 162/104 20.015 (0.043) 20.025 (0.069)
Attendance rate in exercise sessions (0–100),
median (IQR)
166/106 12.2 (77.8) 0.0 (69.1)
*Except when indicated otherwise, values are mean (SD); p,0.05 Mann-Whitney U test fast increase in damage
v slow increase in damage subgroup.
Fast increase in damage is defined as a change in the Larsen score higher than the mean change for the whole
group of completers (.4.67); slow increase in damage is defined as a change in Larsen score equal to or lower
than the mean change ( 4.67).
AUC DAS4, area under curve disease activity score four variables; DMARDs, disease modifying antirheumatic
drugs; BMD, bone mineral density; IQR, interquartile range. IQR is expressed as a net result of 25th–75th centile.
Table 4 Univariate and multivariate analysis* of risk factors for change in radiological
damage of the small joints in 281 completers of the RAPIT study
Univariate
column 1
Multivariate
column 2
Stepwise selected
column 3
Baseline Larsen score small joints 0.05 (0.01)` 0.04 (0.02)` 0.05 (0.02)`
AUC DAS4 0.32 (0.07)` 0.22 (0.07)` 0.21 (0.07)`
Use of DMARDs 2.67 (1.43) 1.14 (1.43)
Use of glucocorticoids 0.24 (0.13)` 0.17 (0.09) 0.16 (0.08)
Change in muscle strength 20.01 (0.02) 20.03 (0.02)
Change in aerobic fitness 20.04 (0.02) 20.01 (0.02) 20.04 (0.01)
Change in BMD 218.45 (10.41) 21.59 (10.20)
Attendance rate in exercise sessions 20.03 (0.02) 20.03 (0.02)
*Linear regression analysis; results given as unstandardised regression coefficients (B) with standard error (SE) and
a level of significance (p).
p,0.05; `p,0.005.
AUC DAS4, area under the curve disease activity score four variables; DMARDs, disease modifying antirheumatic
drugs; BMD, bone mineral density.
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DAS4), and changes in the use of DMARDs and of
glucocorticoids (range 0–24) during the study period.
Additional variables were change in muscle strength and in
aerobic fitness, and the change in BMD after 2 years. To
account for the possibility of exercise modalities potentially
influencing the rate of bone loss—for example, by impact
loading or versatile movements, and which might not be
accounted for by the changes in muscle strength or aerobic
fitness, attendance rate was also included in the model.
Univariate analyses show (table 4, column 1) that the
following factors were significantly associated with increased
rate of damage: higher baseline radiological damage (Larsen
score), higher disease activity (AUC DAS4), more frequent
use of glucocorticoids, and lower attendance rate at the
exercise sessions. To analyse the relationship between the
outcome variable and these factors simultaneously, a multi-
variate analysis was performed (table 4, column 2). This
demonstrates that a higher rate of damage is independently
predicted by higher baseline damage (unstandardised regres-
sion coefficient (standard error); 0.04 (0.02), p,0.005),
higher disease activity (0.22 (0.07), p,0.005), more frequent
use of glucocorticoids (0.17 (0.09), p,0.05), and a decrease
in aerobic fitness (20.01 (0.02), p,0.05). In the backwards-
stepwise selection of significant covariates (table 4, column
3), baseline damage, disease activity, use of glucocorticoids,
and change in aerobic fitness remained in the model.
DISCUSSION
The data from this large randomised controlled trial (RAPIT
trial) suggest that patients with RA participating in long term
high intensity weightbearing exercise classes develop less
radiological joint damage in the feet than patients participat-
ing in usual care physical therapy. In addition to the decrease
in disease activity and in the use of glucocorticoids (disease
related factors), an increase in aerobic fitness (exercise
related factor) independently predicts a decrease in the rate
of damage.
Previous investigations on the effects of intensive exercise
on joint damage have been contradictory. In a non-
randomised controlled trial by Nordemar et al,13 46 patients
with RA participating in a long term exercise programme
were studied for 4–6 years. Only those joints in the lower
extremities which had ever shown any arthritic features were
analysed before and after the study by radiography. The
authors claimed that there was more pronounced radiological
progression in these joints in the non-training group than in
the training group. Hansen et al examined the effectiveness
and safety of four different exercise programmes in 75
patients with RA participating in a 2 year randomised
controlled trial.14 No effects were noted either on aerobic
fitness and/or muscle strength, or on the rate of damage of
the small joints. Stenstro¨m et al investigated the effects of a
long term aquatic exercise on the rate of damage of the joints
of hands and feet in 60 patients with RA and also found no
difference between the groups.15 Ha¨kkinen et al included 70
patients with early RA in their well designed randomised
controlled trial on the effectiveness of long term high
intensity weightbearing muscle strengthening exercises.16
They observed that these exercises, effective in increasing
muscle strength and physical function, did not affect the rate
of damage of the small joints. This lack of consistency in
reported results is probably a consequence of factors such as
different trial designs, a questionable trial design,13 low
number of participants,13–16 and/or either lack of weight-
bearing.15
This is the first time that improvement in aerobic fitness has
been shown to predict, independently of other factors, a
decrease in the rate of local bone damage. This finding seems
to be in concordancewith our earlier observation demonstrating
that improvement in aerobic fitness is associated with a
decreased rate of systemic bone loss.12 These observations are
also in agreement with the currently accepted mechanism on
the development of bone loss in patients with RA.26 27
What does aerobic fitness represent? Change in aerobic
fitness was in our study brought about by diverse exercises,
such as bicycling, as well as by stepping, stair walking, sport,
and game activities, which also generate impact loading. It
has been suggested that loading of the skeleton by
weightbearing and impact delivering exercises activates bone
remodelling and, if sufficiently powerful, results in a net
increase in the BMD and production of bone more resistant
to stress.26 27 This hypothesis seems to be supported in our
study by the finding that the decrease in erosion rate of the
hand and feet joints is most pronounced in the feet joints,
which were, naturally, more subject to loading than the joint
of the hands.
On the cellular level, the osteoclast is presumed to be the
final common cell in local and systemic bone destruction. The
role of the osteoclast is supported by recent investigations on
a serum transfer model of arthritis, which leads in wild-type
mice to severe bone erosions.28 Evidence suggests that an
essential step in the development of bone erosions is the
degradation of bone matrix by osteoclasts and that the
differentiation and activation of osteoclasts is mediated by
the RANK-RANKL axis.29–32 Starting from these findings
obtained by laboratory research and from recent cross
sectional studies on patients with RA,6 7 we might hypothe-
sise that local and systemic bone loss in patients with RA is
also interrelated with a common effector cell, the osteoclast.
If this applies, we would then expect that the change in BMD
would predict the rate of bone erosion-radiological joint
damage. In our study group we were not able to demonstrate
such a relationship. However, the exercises increased the
BMD as shown by DXA of the hip, which is a measure of
change in radiographic bone density but does not provide
information on quality, strength, and resistance of bone and
cartilage towards mechanical and inflammatory stress.
From a clinical-epidemiological point of view, bias in our
study is possible. The target sample size of the RAPIT study
was based on the ability to detect a clinically relevant change
in the HAQ score and not on the ability to assess the effect on
joint erosions, nor to determine the risk factors for progres-
sion of erosions. We estimated that, with the sample size of
about 150 patients in each treatment group and the observed
standard deviation of the change of the Larsen score after
2 years of 9.2, the detectable difference between (treatment)
groups is about 3 (80% power). However, despite the fact that
the study was underpowered to find a clinically relevant
difference, we found a small but statistically significant (but
possibly not clinically relevant) difference between the
groups. This finding provides clinical support for the current
view of an association between the increase of bone density
by exercise and the progression of joint damage.
The randomisation procedure created two groups, which
differed in their disease duration and radiological baseline
damage of the small joints (Larsen score). The eventual UC
group completers are patients with a longer RA duration and
as a consequence, more radiological joint damage than the
completers of the exercise group. These differences were
probably caused by withdrawal of nine patients (eight from
the UC group and one from the exercise group) directly after
the randomisation (fig 1). It can be argued that the
differences in joint damage progression found in our study
are due to these post-randomisation effects, which created
groups with a different disease course.
There are several arguments against such bias. Firstly,
recent publications show that the rate of damage progression
is independent of the RA duration.33 Secondly, it should be
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noted that disease activity or use of DMARDs and gluco-
corticoids did not differ between the exercise and the UC
group at any time. Finally, separate analysis of the hand and
feet joints demonstrated that at baseline the inequality in
damage between the groups was present for the largest part
in the hands, whereas it was the feet joints which seem to
profit most from exercising.
Nevertheless, we have corrected for the differences at
baseline wherever present and demonstrate that the mean
differences in change between the groups after correction for
these differences were, indeed, in favour of the exercise
group.
The evidence on radiological damage of the small joints is
based on readings of the radiographs by a single observer. It
might be argued that reported data suggest that more than
one observer should be used to minimise the bias.34 However,
the mean difference (SD) of test-retest of the single observer
(0.69 (6.7)), the intraobserver intraclass correlation coeffi-
cient (0.96), and the SDD based on the progression score
(11.5) were satisfactory given the size of the study.
In conclusion, we provide evidence that participation in a
long term high intensity weightbearing exercise programme
comprising improvement in aerobic fitness and impact
generating activities does not increase the rate of radiological
joint damage of the hands and feet in patients with RA. On
the contrary, it seems that these exercises have a protective
effect for the joints of the feet.
Because the underlying pathophysiological mechanism is
not fully elucidated more research should be done on the
effects of high intensity weightbearing exercises and cartilage
metabolism.
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